"CIS is a potent checkpoint in NK cell-mediated tumor immunity" by Rebecca B. Delconte, Tatiana B. Kolesnik et al.
 

Paediatrics Publications

Document Type

Article

Publication Date

6-21-2016

Journal

Nature Immunology

Volume

17

Issue

7

First Page

816

Last Page

824

URL with Digital Object Identifier

10.1038/ni.3470

Abstract

The detection of aberrant cells by natural killer (NK) cells is controlled by the integration of signals from activating and inhibitory ligands and from cytokines such as IL-15. We identified cytokine-inducible SH2-containing protein (CIS, encoded by Cish) as a critical negative regulator of IL-15 signaling in NK cells. Cish was rapidly induced in response to IL-15, and deletion of Cish rendered NK cells hypersensitive to IL-15, as evidenced by enhanced proliferation, survival, IFN-γ production and cytotoxicity toward tumors. This was associated with increased JAK-STAT signaling in NK cells in which Cish was deleted. Correspondingly, CIS interacted with the tyrosine kinase JAK1, inhibiting its enzymatic activity and targeting JAK for proteasomal degradation. Cish -/- mice were resistant to melanoma, prostate and breast cancer metastasis in vivo, and this was intrinsic to NK cell activity. Our data uncover a potent intracellular checkpoint in NK cell-mediated tumor immunity and suggest possibilities for new cancer immunotherapies directed at blocking CIS function.

Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 282
    • Patent Family Citations: 2
  • Usage
    • Downloads: 165
    • Abstract Views: 3
  • Captures
    • Readers: 343
  • Mentions
    • Blog Mentions: 1
    • News Mentions: 2
  • Social Media
    • Shares, Likes & Comments: 21
see details

Share

COinS